ArticleBMC pulmonary medicine2026

An integrated host vulnerability score is associated with survival in advanced NSCLC treated with nivolumab: a PET/CT-based real-world study.

Vali Aliyev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.